Skip to main content

Table 2 Prevalence of comorbid conditions by sex among lung cancer patients in urban China

From: Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China

 

Female

(n = 3994)

Male

(n = 6181)

Total

(n = 10,175)

Numbers of comorbidity

 0, n(%)

2746 (68.8)

4154 (67.2)

6900 (67.8)

 1, n(%)

869 (21.8)

1336 (21.6)

2205 (21.7)

 2, n(%)

309 (7.7)

539 (8.7)

848 (8.3)

 3+, n(%)

70 (1.8)

152 (2.5)

222 (2.2)

Comorbidity

 Other malignancy, n(%)

318 (8.0)

448 (7.2)

766 (7.5)

 Hypertension, n(%)

238 (6.0)

313 (5.1)

551 (5.4)

 Pulmonary disease, n(%)

71 (1.8)

309 (5.0)

380 (3.7)

 Diabetes mellitus, n(%)

97 (2.4)

154 (2.5)

251 (2.5)

 Liver disease, n(%)

124 (3.1)

118 (1.9)

242 (2.4)

 Cardiovascular disease, n(%)

87 (2.2)

150 (2.4)

237 (2.3)